{"url_path":"/sec/skye/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Legal Proceedings","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-11","source_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","accession_number":"0001628280-26-033417","cik":"0001516551","ticker":"SKYE","issuer_name":"Skye Bioscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1516551/0001628280-26-033417-index.html","primary_entity_key":"0001516551","primary_entity_name":"Skye Bioscience, Inc."},"word_count":34,"has_tables":true,"body_markdown":"Item 1. Legal Proceedings\n\nFor a description of material legal proceedings, see Note 8, \"General Litigation and Disputes\" to the accompanying unaudited condensed consolidated financial statements included in this Quarterly Report on Form 10-Q."}